By Jamelle Bouie Opinion Columnist On Tuesday, the Presidential Commission on the Supreme Court of the United States sat for its third public meeting. Formed in April by executive order, […]
Your Thursday Briefing
The countries trying to ‘live with Covid’ Eighteen months into the pandemic, governments in Asia, Europe and the Americas are encouraging people to return to life as it once was […]
Opinion | Kara Goes to the Olympics
Produced by ‘Sway’ People love the Olympics. But this year’s Games, which open on Friday, are plagued with controversial suspensions and public pushback, not to mention the pandemic. How did […]
Opinion | It Seems Odd That We Would Just Let the World Burn
By Ezra Klein Opinion Columnist I spent the weekend reading a book I wasn’t entirely comfortable being seen with in public. Andreas Malm’s “How to Blow Up a Pipeline” is […]
Opinion | Medical Miracles: When Patients Defy the Odds
More from our inbox: To the Editor: Re “When Doctors Experience a Miracle,” by Daniela J. Lamas (Sunday Review, July 4): For those of us who perhaps didn’t wait long […]
Opinion | Fight Vaccine Hesitancy With Mandates?
More from our inbox: To the Editor: Re “Biden Resists Call to Support Vaccine Edicts” (front page, July 7): Have we forgotten the concept of public health? Taking an action […]
Building it better – US takes on China's Belt and Road project
Power Play is a weekly column that looks at various facets of US-China rivalry and its implications for Asia. At the recent Group of Seven (G-7) meeting in England, US […]
Tate & Lyle to sell stake in commercial sweetener unit in $1.7 billion deal
The factory of Tate & Lyle Sugars is seen in London, Britain January 27, 2021. REUTERS/Peter Cziborra(Reuters) – Tate & Lyle Plc said on Monday it had agreed to sell […]
Opinion | California’s Peculiar Brand of Populism Misses the Point
By Ezra Klein Opinion Columnist After a slow start, California ranks 10th in the nation for coronavirus vaccinations. It’s down to about three cases per 100,000 residents. Its economy is […]
Platinum Equity to buy specialty chemicals maker Solenis in $5.25 billion deal
(Reuters) -Billionaire Tom Gores’ private equity firm Platinum Equity said on Tuesday it would buy specialty chemicals maker Solenis in a deal valued at $5.25 bln, including debt, and merge […]